We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

Pushing the Boundaries of Translational Molecular Imaging
Industry Insight

Professor Ron Heeren recently embarked on a study to bring together the spatial molecular information that is provided by MALDI-MSI with the microproteomic characterization generated by LC-MS on the same tissue specimen, on a single instrument. Heeren and colleagues were successful in this feat. Their work is published in the journal Proteomics and forms the basis of this interview.

Read More

A New SARS-CoV-2 Descriptive Diagnostic Test – What Makes This Assay Different to Others?
Industry Insight

Clear Labs is a company focused on the latest technologies in molecular testing, machine learning, automation and bioinformatics – it develops fully automated next-generation sequencing and in vitro diagnostics solutions. Technology Networks had the pleasure of speaking with ClearLabs’ CEO Sasan Amini, to learn more about the company’s NGS-based COVID test, Clear Dx™.

Read More

LAMP-Based Testing for COVID-19
Industry Insight

Technology Networks recently spoke to Dr Gary Keating, Chief Technical Officer at Hibergene Diagnostics, to learn more about LAMP technology and the advantages it could offer for COVID-19 testing. Gary also discussed some of the challenges faced when developing diagnostics and how the COVID-19 pandemic has impacted diagnostic design and manufacturing.

Read More

COVID-19 Antibody Testing: S vs. N Protein
Industry Insight

Technology Networks spoke to Dr Iswariya Venkataraman, Scientific Affairs Lead at EUROIMMUN US, to learn about the differences between the S and N proteins and what makes them suitable as target antigens in serology testing. Iswariya also discussed the findings and implications from a study which cautioned against the extensive use of tests that detect antibodies against the N protein only.

Read More

Exploring SARS-CoV-2 Antibody Testing
Industry Insight

Technology Networks spoke to Jeff Hawkins, Dr Jerry Yeo, and Dr Abhijit Datta, to learn how the information provided by antibody tests can be used appropriately during the COVID-19 pandemic.

Read More

Tapping Into Information Locked in Our T Cells To Fight COVID-19
Industry Insight

T cells are an important part of our immune memory and offer a wealth of valuable information about the way our bodies perceive and respond to pathogens. Learn how this information is being harnessed and applied in the fight against COVID-19.

Read More

Ultra-High-Throughput Proteomics To Discover New Biomarkers To Predict COVID-19 Severity
Industry Insight

In a study recently published in Cell Systems, a new ultra-high-throughput proteomics method was used to identify 27 blood biomarkers that distinguished COVID-19 patients with mild or severe responses. We spoke to Dr Markus Ralser to learn more about the study and how the method could potentially be used in the clinic to diagnose COVID-19 severity.

Read More

Progress in Companion Diagnostic Development for Low-Grade Glioma
Industry Insight

To learn about the benefits of accelerating turnaround times for genomic testing and the importance of partnering with pharma companies to develop companion diagnostics, Technology Networks spoke with Luca Quagliata, PhD, BCMAS, Global Director of Medical Affairs for Thermo Fisher Scientific.

Read More

The Science Behind Saliva-Based Rapid Diagnostic Testing
Industry Insight

Here, Dr Pretorius examines the use of saliva, rather than blood, in rapid diagnostic tests for malaria and how this clinically informative biofluid could help to improve healthcare in the world’s poorest regions.

Read More

New RNA Extraction Strategies Help Mitigate Shortages in SARS-CoV-2 PCR Components
Industry Insight

As the world continues to battle through the pandemic, developing innovative strategies to expand the availability of extraction, and any other testing components that are facing supply issues, will be an ongoing requirement.

Read More

 
Advertisement